1. Home
  2. CRMT vs VYGR Comparison

CRMT vs VYGR Comparison

Compare CRMT & VYGR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo America's Car-Mart Inc

CRMT

America's Car-Mart Inc

HOLD

Current Price

$25.84

Market Cap

266.5M

ML Signal

HOLD

Logo Voyager Therapeutics Inc.

VYGR

Voyager Therapeutics Inc.

HOLD

Current Price

$4.06

Market Cap

226.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CRMT
VYGR
Founded
1981
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Other Specialty Stores
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
266.5M
226.8M
IPO Year
N/A
2015

Fundamental Metrics

Financial Performance
Metric
CRMT
VYGR
Price
$25.84
$4.06
Analyst Decision
Buy
Strong Buy
Analyst Count
2
6
Target Price
$37.00
$17.00
AVG Volume (30 Days)
186.9K
381.5K
Earning Date
12-04-2025
11-10-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$1,381,482,000.00
$31,316,000.00
Revenue This Year
$2.84
N/A
Revenue Next Year
$5.05
$71.78
P/E Ratio
N/A
N/A
Revenue Growth
2.01
N/A
52 Week Low
$17.78
$2.65
52 Week High
$62.72
$6.27

Technical Indicators

Market Signals
Indicator
CRMT
VYGR
Relative Strength Index (RSI) 54.63 46.19
Support Level $24.11 $3.82
Resistance Level $26.61 $4.26
Average True Range (ATR) 1.57 0.20
MACD -0.11 -0.01
Stochastic Oscillator 44.46 30.56

Price Performance

Historical Comparison
CRMT
VYGR

About CRMT America's Car-Mart Inc

America's Car-Mart Inc is an automotive retailer in the U.S. focused exclusively on the Integrated Auto Sales and Finance segment of the used car market. The company's operations are principally conducted through its two operating subsidiaries, America's Car Mart Inc and Colonial Auto Finance. It predominantly sells older model used vehicles and provides financing for substantially all of its customers. It earns revenue from the sale of used vehicles and, in the majority of cases, a related service contract and an accident protection plan product, as well as interest income and late fees from the related financing.

About VYGR Voyager Therapeutics Inc.

Voyager Therapeutics Inc is a gene therapy company focused on developing life-changing treatments for patients suffering from severe neurological diseases. It focuses on neurological diseases where an adeno-associated virus, or AAV, gene therapy approach that either increases or decreases the production of a specific protein can slow or reduce the symptoms experienced by patients, and therefore have a clinically meaningful impact. The company's gene therapy platform TRACER enables to engineer, optimize, manufacture and deliver AAV-based gene therapies that have the potential to provide durable efficacy following a single administration. Its pipeline of programs include, Anti-tau Antibody (VY-TAU01), SOD1 Silencing Gene Therapy (siRNA), FXN Gene Therapy among others.

Share on Social Networks: